Literature DB >> 22986897

The expression of metabolism-related proteins in phyllodes tumors.

Ji Eun Kwon1, Woo-Hee Jung, Ja Seung Koo.   

Abstract

The purpose of this study was to investigate the association between the expression of hypoxia-inducible factor (HIF)-1α, insulin-like growth factor (IGF)-1, glucose transporter 1 (Glut-1), carbonic anhydrase IX (CAIX), and monocarboxylate transporter (MCT)4, which are metabolism-related proteins in phyllodes tumors (PTs), and clinicopathologic factors and its implication. We used tissue microarrays to analyze 207 PTs and performed immunohistochemical staining against the glycolysis-related molecules HIF-1α, IGF-1, Glut-1, CAIX, and MCT4. We then compared the immunohistochemical results and clinicopathologic parameters. The expressions of HIF-1α, Glut-1, CAIX, and MCT4 in the stromal component of PTs increased (P = 0.019, P < 0.001, P = 0.045, and P < 0.001, respectively) with increasing tumor grade. According to univariate analysis, factors associated with shorter disease-free survival were Glut-1 expression (P = 0.001) and MCT4 expression (P < 0.001) in the stromal component, and the factors associated with shorter overall survival were IGF-1 expression (P = 0.012), Glut-1 expression (P < 0.001), CAIX expression (P = 0.039), and MCT4 expression (P < 0.001) in the stromal component. Our investigation of stromal expression of the metabolism-related proteins HIF-1α, IGF-1, Glut-1, CAIX, and MCT4 revealed that, as the PT grade increased, the stromal expression of HIF-1α, Glut-1, CAIX, and MCT4 significantly increased. This result suggested that increasing PT grade is associated with increased glycolysis in the stromal component.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986897     DOI: 10.1007/s13277-012-0518-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  36 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

Authors:  Eun-Jin Yeo; Yang-Sook Chun; Young-Suk Cho; Jinho Kim; June-Chul Lee; Myung-Suk Kim; Jong-Wan Park
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

Review 3.  Glucose metabolism and cancer.

Authors:  Reuben J Shaw
Journal:  Curr Opin Cell Biol       Date:  2006-10-12       Impact factor: 8.382

4.  Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.

Authors:  S K Chia; C C Wykoff; P H Watson; C Han; R D Leek; J Pastorek; K C Gatter; P Ratcliffe; A L Harris
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

5.  Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer.

Authors:  Bodiford Lee Stackhouse; Holly Williams; Paul Berry; Greg Russell; Pamela Thompson; Jerald L Winter; Timothy Kute
Journal:  Breast Cancer Res Treat       Date:  2005-10       Impact factor: 4.872

6.  GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.

Authors:  M Younes; R W Brown; D R Mody; L Fernandez; R Laucirica
Journal:  Anticancer Res       Date:  1995 Nov-Dec       Impact factor: 2.480

Review 7.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.

Authors:  Daniela Vullo; Marco Franchi; Enzo Gallori; Jaromir Pastorek; Andrea Scozzafava; Silvia Pastorekova; Claudiu T Supuran
Journal:  Bioorg Med Chem Lett       Date:  2003-03-24       Impact factor: 2.823

9.  Clonal analysis of fibroadenoma and phyllodes tumor of the breast.

Authors:  S Noguchi; K Motomura; H Inaji; S Imaoka; H Koyama
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

10.  Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.

Authors:  Saskia E Rademakers; Jasper Lok; Albert J van der Kogel; Johan Bussink; Johannes H A M Kaanders
Journal:  BMC Cancer       Date:  2011-05-12       Impact factor: 4.430

View more
  8 in total

1.  The expression of glutamine-metabolism-related proteins in breast phyllodes tumors.

Authors:  Sewha Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Tumour Biol       Date:  2013-05-01

2.  Recurrent borderline phyllodes tumor in nipple: a rare case report and review of the literature.

Authors:  Denghua Sun; Lu Tang; Hua Xing; Lijuan Zhang; Le Zhang
Journal:  Gland Surg       Date:  2020-04

3.  Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness.

Authors:  Julieta Afonso; Lúcio L Santos; António Morais; Teresina Amaro; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Cell Cycle       Date:  2015-12-04       Impact factor: 4.534

4.  Expression of autophagy-related proteins in phyllodes tumor.

Authors:  Sang Kyum Kim; Woo Hee Jung; Ja Seung Koo
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

5.  Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.

Authors:  David J Stewart; Maria I Nunez; Carmen Behrens; Diane Liu; Yan Heather Lin; J Jack Lee; Jack Roth; John Heymach; Stephen G Swisher; Waun Ki Hong; Ignacio Ivan Wistuba
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

Review 6.  Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors.

Authors:  Olga Sedlakova; Eliska Svastova; Martina Takacova; Juraj Kopacek; Jaromir Pastorek; Silvia Pastorekova
Journal:  Front Physiol       Date:  2014-01-08       Impact factor: 4.566

Review 7.  The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.

Authors:  Min Yu; Han Yongzhi; Shengying Chen; Xiaodan Luo; Ye Lin; Yu Zhou; Haosheng Jin; Baohua Hou; Yanying Deng; Lei Tu; Zhixiang Jian
Journal:  Oncotarget       Date:  2017-06-27

Review 8.  Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.

Authors:  Cory D Bovenzi; James Hamilton; Patrick Tassone; Jennifer Johnson; David M Cognetti; Adam Luginbuhl; William M Keane; Tingting Zhan; Madalina Tuluc; Voichita Bar-Ad; Ubaldo Martinez-Outschoorn; Joseph M Curry
Journal:  Biomed Res Int       Date:  2015-12-08       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.